Diagnostics Pipeline: More AI-Reliant Platforms Being Approved by the FDA
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
This checklist can help labs monitor their organization’s business arrangements that concern digital pathology to ensure compliance.
Healthcare attorneys explain three digital pathology models for laboratories to be aware of.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Juan Antonio Retamero, MD, shares his thoughts on recent trends in AI and digital pathology, and how they may progress.